BROLUCIZUMAB (BEOVU) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

BROLUCIZUMAB

What is the Trade Name for BROLUCIZUMAB

BEOVU

What is the Indication for BROLUCIZUMAB

  • 1 INDICATIONS AND USAGE BEOVU ¬Æ is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1 ).

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]